💨 Abstract
A Pune-based biopharmaceutical company, Gennova, has secured funding from the Coalition for Epidemic Preparedness Innovations (CEPI) to advance the development of a vaccine against the deadly Nipah virus. The virus, with no approved vaccines or treatments, is known to kill 75% of those infected.
Courtesy: theprint.in
Summarized by Einstein Beta 🤖
Suggested
Mumbai court issues non-bailable warrant against Mehul Choksi in loan fraud case
Indian soldiers defeat Pakistan each time it dares to challenge country''s unity, strength: Himanta
Rig Vedic scholar Satya Chandrashekarendra anointed as junior pontiff of Kanchi Kamakoti Peetam
2024 protest case: Delhi court exempts TMC leaders from personal appearance
K Raheja Corp Homes: Pioneering Self-Contained Communities
Congress state chief YS Sharmila complains of house arrest
BGMI Rolls Out more Rewards; Latest Redeem Codes Promise Enhanced In-Game Customization
Pakistan: Imran Khan's sister slams authorities for not allowing her to meet him in jail
UiPath Launches Global AgentHack 2025 at DevCon Bengaluru
Bhagwant Mann is trying to divide Punjab, Haryana by raising water issue now: Bittu
Powered by MessengerX.io